Emergent closes on buying smallpox drug Tembexa from Chimerix with a $238M payment
It was only last year that the oral treatment Tembexa was approved by the FDA to treat smallpox, but the drug has already changed hands …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
